• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

MYLS22

CAS No. 306959-01-3

MYLS22 ( —— )

产品货号. M23118 CAS No. 306959-01-3

MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥284 有现货
5MG ¥462 有现货
10MG ¥786 有现货
25MG ¥1345 有现货
50MG ¥2049 有现货
100MG ¥3167 有现货
200MG ¥4755 有现货
500MG ¥7525 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    MYLS22
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.
  • 产品描述
    MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor. MYLS22 can target endothelial OPA1 to curtail tumor growth and inhibits angiogenesis by impinging on NFkB activity and on angiogenic gene expression.
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    OPA1
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    306959-01-3
  • 分子量
    443.5
  • 分子式
    C??H??N?O?S
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO : 50 mg/mL (112.73 mM; ultrasonic and warming and heat to 60°C)
  • SMILES
    ——
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Stéphanie Herkenne, et al. Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1. Cell Metab. 2020 May 5;31(5):987-1003.e8.
产品手册
关联产品
  • (R,S)-Equol

    S-equol and R/S-equol estrogen receptor α2-selective phytoSERM treatments have potentiation of brain mitochondrial function.

  • Microhelenin C

    Microhelenin C has significant antileukemic activity.

  • Fuzitine

    The flowers of Magnolia liliiflora Desr.